Ray Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 9.50 M
- Company Age 33 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 11.57 Cr
- Revenue Growth 169.15%
- Profit Growth 41.56%
- Ebitda -3.28%
- Net Worth -12.54%
- Total Assets 12.98%
About Ray Life Sciences
Ray Life Sciences Private Limited (RLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 September 1991 and has a history of 33 years and four months. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Raylife Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 9.50 M.
The company has closed loans amounting to ₹11.57 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anjan Roy, Trishna Roy, Tanushree Roy, and One other member serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24111KA1991PTC012343
- Company No.
012343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 1991
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Ray Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjan Roy  | Whole-Time Director | 20-Nov-1992 | Current |
| Trishna Roy | Whole-Time Director | 05-Oct-2001 | Current |
| Tanushree Roy | Whole-Time Director | 30-Sep-2005 | Current |
| Sumitra Roy | Whole-Time Director | 24-Sep-1991 | Current |
Financial Performance of Ray Life Sciences.
Ray Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 169.15% increase. The company also saw a substantial improvement in profitability, with a 41.56% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ray Life Sciences?
Unlock access to Ray Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Flowchem Pharma Private LimitedAnjan Roy and Trishna Roy are mutual person
Trroy Life Sciences Private LimitedAnjan Roy, Trishna Roy and 2 more are mutual person
Charges (Loans)
₹0
₹11.57 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 7.00 Cr
- State Bank Of India : 4.20 Cr
- Canara Bank : 0.22 Cr
- Ksfc : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2019 | Axis Bank Limited | ₹7.00 Cr | Satisfied |
| 16 Nov 2002 | State Bank Of India | ₹4.20 Cr | Satisfied |
| 30 Jun 1993 | Ksfc | ₹1.50 M | Satisfied |
| 23 Feb 1984 | Canara Bank | ₹2.20 M | Satisfied |
How Many Employees Work at Ray Life Sciences?
Ray Life Sciences has a workforce of 83 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ray Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ray Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.